Dual species interactions shield Campylobacter against multiple antibiotics
Sangeeta BanerjiiD, Gudrun HollandiD, Michael M. LaueiD, Antje FliegeriD
Abstract
BackgroundCampylobacter is a major food-borne pathogen causing diarrhea. In severe cases, treatment typically involves fluoroquinolones (FQ) and macrolides. However, high proportions of FQ resistance (FQR) have made macrolides the remaining first-line treatment option. As part of the Campylobacter surveillance program in Germany, we investigated multidrug resistance (MDR) in clinical Campylobacter samples collected 2010 to 2022. MethodsA total of 6,980 samples was single-colony purified and analyzed for antimicrobial resistance phenotypes. Genome sequencing was performed for 2,912 samples, and antimicrobial resistance genes were mapped. Cultures showing MDR were further analyzed for contaminating DNA and studied using scanning electron microscopy (SEM). FindingsWe found that 453 (6%) Campylobacter samples were resistant to both FQ and macrolides. Two of the C. jejuni samples were resistant to antibiotics from ten different classes. Genome analysis revealed that these samples, despite being derived from single colonies, contained >10% Enterococcus DNA reads. SEM confirmed the presence of coccoid bacteria interspersed with spiral-shaped Campylobacter. Additional culture-based purification resulted in pure C. jejuni isolates that retained FQR but lost macrolide resistance. We further showed that presence of MDR Enterococcus spp. in the mixed samples protected C. jejuni from above-MIC (minimum inhibitory concentration) of several ribosome-targeting antimicrobials whereas pure Campylobacter were susceptible. These findings revealed that Campylobacter may gain antimicrobial resistance advantages through close interactions with Enterococcus spp. InterpretationMDR phenotypes in Campylobacter cultures may arise through close, dual-species interactions with other highly resistant intestinal bacteria, such as MDR Enterococcus spp. and may have practical implications for antibiotic treatment. FundingThis study was funded by the German Ministry of Health dedicated to the National Reference Centre for Salmonella and other Bacterial Enteric Pathogens.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Genomic screening of antimicrobial resistance markers in UK and US Campylobacter isolates highlights stability of resistance over an 18 year period
A. H. M. van Vliet, S. Thakur, … R. La Ragione·bioRxiv·Aug 24, 2021
- Phenotypic Resistance of Ciprofloxacin and Azithromycin Resistant Campylobacter Isolates to an Extended Panel of Antibiotics.
Lucero Romaina Cachique, Francesca Schiaffino, … Margaret N. Kosek·bioRxiv·Feb 10, 2026
- Genetic diversity and antimicrobial resistance of Campylobacter jejuni isolates from Gambian children under five with moderate-to-severe diarrhoea and healthy Controls
Modupeh Betts, Michel Mainack Dione, … Martín Antonio·bioRxiv·Jul 30, 2024
- Whole genome-based Characterization of Virulence and Antimicrobial Resistance Determinants in Clinical Campylobacter jejuni Isolates from Minnesota, 2018-2021
Haejin Hwang-Hinz, Melanie Orth, … Jisun S. Haan·Journal of Clinical MicrobiologyPeer-reviewed·Oct 27, 2026
- Development of fluoroquinolone resistance through antibiotic tolerance in Campylobacter jejuni
- Genomic analysis of the diversity, antimicrobial resistance and virulence potential of Campylobacter jejuni and Campylobacter coli strains from Chile
V. Bravo, A. Katz, … C. J. Blondel·bioRxiv·Jul 3, 2020